BIOMAT Database Logo BIOMAT Database Logo

Statins, ventricular arrhythmias and heart rate variability in patients with implantable cardioverter defibrillators and coronary heart disease. 2005

Sam Riahi, and Erik Berg Schmidt, and Jeppe Hagstrup Christensen, and Finn Heath, and Anders Kirstein Pedersen, and Jens Cosedis Nielsen, and Henning Mølgaard, and Egon Toft
Department of Cardiology, Cardiovascular Research Center, Aalborg Hospital, Arhus University, Aalborg, Denmark. samriahi@dadlnet.dk

The aim of this study was to evaluate whether the incidence of ventricular arrhythmias and heart rate variability were influenced by statin treatment and lipid levels in patients treated with an implantable cardioverter defibrillator (ICD). Heart rate variability measurements were performed in 86 patients with coronary heart disease and an ICD implant. The number of events with ventricular fibrillation and ventricular tachycardia were recorded during a 12-month period. This study lends little support for an antiarrhythmic effect of statins or any relation between plasma lipids and lipoproteins and malignant ventricular arrhythmias in patients with an ICD.

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000319 Adrenergic beta-Antagonists Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. Adrenergic beta-Antagonist,Adrenergic beta-Receptor Blockader,Adrenergic beta-Receptor Blockaders,beta-Adrenergic Antagonist,beta-Adrenergic Blocker,beta-Adrenergic Blocking Agent,beta-Adrenergic Blocking Agents,beta-Adrenergic Receptor Blockader,beta-Adrenergic Receptor Blockaders,beta-Adrenoceptor Antagonist,beta-Blockers, Adrenergic,beta-Adrenergic Antagonists,beta-Adrenergic Blockers,beta-Adrenoceptor Antagonists,Adrenergic beta Antagonist,Adrenergic beta Antagonists,Adrenergic beta Receptor Blockader,Adrenergic beta Receptor Blockaders,Adrenergic beta-Blockers,Agent, beta-Adrenergic Blocking,Agents, beta-Adrenergic Blocking,Antagonist, beta-Adrenergic,Antagonist, beta-Adrenoceptor,Antagonists, beta-Adrenergic,Antagonists, beta-Adrenoceptor,Blockader, Adrenergic beta-Receptor,Blockader, beta-Adrenergic Receptor,Blockaders, Adrenergic beta-Receptor,Blockaders, beta-Adrenergic Receptor,Blocker, beta-Adrenergic,Blockers, beta-Adrenergic,Blocking Agent, beta-Adrenergic,Blocking Agents, beta-Adrenergic,Receptor Blockader, beta-Adrenergic,Receptor Blockaders, beta-Adrenergic,beta Adrenergic Antagonist,beta Adrenergic Antagonists,beta Adrenergic Blocker,beta Adrenergic Blockers,beta Adrenergic Blocking Agent,beta Adrenergic Blocking Agents,beta Adrenergic Receptor Blockader,beta Adrenergic Receptor Blockaders,beta Adrenoceptor Antagonist,beta Adrenoceptor Antagonists,beta Blockers, Adrenergic,beta-Antagonist, Adrenergic,beta-Antagonists, Adrenergic,beta-Receptor Blockader, Adrenergic,beta-Receptor Blockaders, Adrenergic

Related Publications

Sam Riahi, and Erik Berg Schmidt, and Jeppe Hagstrup Christensen, and Finn Heath, and Anders Kirstein Pedersen, and Jens Cosedis Nielsen, and Henning Mølgaard, and Egon Toft
Heart rate variability before ventricular arrhythmias in patients with coronary artery disease and an implantable cardioverter defibrillator.
July 2003, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc,
Sam Riahi, and Erik Berg Schmidt, and Jeppe Hagstrup Christensen, and Finn Heath, and Anders Kirstein Pedersen, and Jens Cosedis Nielsen, and Henning Mølgaard, and Egon Toft
Automatic implantable cardioverter-defibrillators in Chagas' heart disease patients with malignant ventricular arrhythmias.
May 2006, Pacing and clinical electrophysiology : PACE,
Sam Riahi, and Erik Berg Schmidt, and Jeppe Hagstrup Christensen, and Finn Heath, and Anders Kirstein Pedersen, and Jens Cosedis Nielsen, and Henning Mølgaard, and Egon Toft
Heart Rate Variability Analysis to Predict Onset of Ventricular Tachyarrhythmias in Implantable Cardioverter Defibrillators.
July 2019, Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference,
Sam Riahi, and Erik Berg Schmidt, and Jeppe Hagstrup Christensen, and Finn Heath, and Anders Kirstein Pedersen, and Jens Cosedis Nielsen, and Henning Mølgaard, and Egon Toft
Weather and triggering of ventricular arrhythmias in patients with implantable cardioverter-defibrillators.
January 2015, Journal of exposure science & environmental epidemiology,
Sam Riahi, and Erik Berg Schmidt, and Jeppe Hagstrup Christensen, and Finn Heath, and Anders Kirstein Pedersen, and Jens Cosedis Nielsen, and Henning Mølgaard, and Egon Toft
Continuous Monitoring of Heart Rate Variability and Clinical Outcomes in Patients with Implantable Cardioverter Defibrillators.
March 2023, Current problems in cardiology,
Sam Riahi, and Erik Berg Schmidt, and Jeppe Hagstrup Christensen, and Finn Heath, and Anders Kirstein Pedersen, and Jens Cosedis Nielsen, and Henning Mølgaard, and Egon Toft
Mortality Risk Increases With Clustered Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators.
March 2020, JACC. Clinical electrophysiology,
Sam Riahi, and Erik Berg Schmidt, and Jeppe Hagstrup Christensen, and Finn Heath, and Anders Kirstein Pedersen, and Jens Cosedis Nielsen, and Henning Mølgaard, and Egon Toft
Inappropriate discharges by fourth generation implantable cardioverter defibrillators in patients with ventricular arrhythmias.
November 2001, Japanese circulation journal,
Sam Riahi, and Erik Berg Schmidt, and Jeppe Hagstrup Christensen, and Finn Heath, and Anders Kirstein Pedersen, and Jens Cosedis Nielsen, and Henning Mølgaard, and Egon Toft
Diurnal, Seasonal, and Monthly Variations in Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators.
August 2019, JACC. Clinical electrophysiology,
Sam Riahi, and Erik Berg Schmidt, and Jeppe Hagstrup Christensen, and Finn Heath, and Anders Kirstein Pedersen, and Jens Cosedis Nielsen, and Henning Mølgaard, and Egon Toft
Exercise performance and training in patients with implantable cardioverter-defibrillators and coronary heart disease.
March 2001, The American journal of cardiology,
Sam Riahi, and Erik Berg Schmidt, and Jeppe Hagstrup Christensen, and Finn Heath, and Anders Kirstein Pedersen, and Jens Cosedis Nielsen, and Henning Mølgaard, and Egon Toft
Heart rate dynamics at the onset of ventricular tachyarrhythmias as retrieved from implantable cardioverter-defibrillators in patients with coronary artery disease.
May 2000, Circulation,
Copied contents to your clipboard!